These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 17089680)
1. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b. Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680 [TBL] [Abstract][Full Text] [Related]
2. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin. López M; González LR; Reyes N; Sotolongo J; Pujol V J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104 [TBL] [Abstract][Full Text] [Related]
3. Some factors affecting the stability of interferon alpha 2b in solution. Ruiz L; Reyes N; Aroche K; Báez R; Aldana R; Hardy E Biologicals; 2006 Mar; 34(1):15-9. PubMed ID: 16188456 [TBL] [Abstract][Full Text] [Related]
4. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing. Santana H; García G; Vega M; Beldarraín A; Páez R PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746 [TBL] [Abstract][Full Text] [Related]
5. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin. Ruiz L; Reyes N; Duany L; Franco A; Aroche K; Hardy Rando E Int J Pharm; 2003 Oct; 264(1-2):57-72. PubMed ID: 12972336 [TBL] [Abstract][Full Text] [Related]
6. Stability of an extemporaneously prepared recombinant human interferon alfa-2b eye drop formulation. Ruiz L; Rodriguez I; Baez R; Aldana R Am J Health Syst Pharm; 2007 Aug; 64(16):1716-9. PubMed ID: 17687060 [TBL] [Abstract][Full Text] [Related]
7. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature. Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990 [TBL] [Abstract][Full Text] [Related]
8. Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying. Santana H; Sotolongo J; González Y; Hernández G; Chinea G; Gerónimo H; Amarantes O; Beldarraín A; Páez R Biologicals; 2014 Nov; 42(6):322-33. PubMed ID: 25190208 [TBL] [Abstract][Full Text] [Related]
9. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ. Osterberg T; Fatouros A; Mikaelsson M Pharm Res; 1997 Jul; 14(7):892-8. PubMed ID: 9244146 [TBL] [Abstract][Full Text] [Related]
10. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam. Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341 [TBL] [Abstract][Full Text] [Related]
11. Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations. Caserman S; Menart V; Gaines Das R; Williams S; Meager A J Immunol Methods; 2007 Jan; 319(1-2):6-12. PubMed ID: 17196611 [TBL] [Abstract][Full Text] [Related]
12. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage. Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475 [TBL] [Abstract][Full Text] [Related]
13. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine. Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697 [TBL] [Abstract][Full Text] [Related]
14. Effect of formulation and freeze-drying on the long-term stability of rDNA-derived cytokines. Dawson PJ Dev Biol Stand; 1992; 74():273-82; discussion 282-4. PubMed ID: 1592176 [TBL] [Abstract][Full Text] [Related]
15. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. Chang BS; Reeder G; Carpenter JF Pharm Res; 1996 Feb; 13(2):243-9. PubMed ID: 8932444 [TBL] [Abstract][Full Text] [Related]
16. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach. Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090 [TBL] [Abstract][Full Text] [Related]